InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001601830-25-000037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-07 2025-03-05+ RXRX Gibson Christopher CEO, Dir S - Sale $6.47 -40.0K 1.26M -3% -$259.0K
DM 2025-03-07 2025-03-05+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +40.0K 1.28M +3% $0
DM 2025-03-07 2025-03-05+ RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -40.0K 5.92M -0.7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-03-06 S D 20,000 $6.37 1,256,024 D — —
2 Common Class A Common Stock 2025-03-06 C A 20,000 $0.00 1,276,024 D — —
3 Common Class A Common Stock 2025-03-05 C A 20,000 $0.00 1,276,024 D — —
4 Common Class A Common Stock 2025-03-05 S D 20,000 $6.58 1,256,024 D — —
5 Derivative Class B Common Stock 2025-03-06 C D 20,000 $0.00 5,896,700 D $0.00 · — to — 20,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
6 Derivative Class B Common Stock 2025-03-05 C D 20,000 $0.00 5,916,700 D $0.00 · — to — 20,000 Class A Common Stock (F3) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.